Lobbying Activity Report
1774-52882
| Organization: | Innovative Medicines Canada (Medicaments novateurs Canada) |
| Associated registration: | 10310-1774-72 |
| Lobbying Activity date: | 2026-06-09 |
| Arranged a meeting: | Yes |
| Posted date: | 2026-07-13 |
| In-house lobbyists who participated in the lobbying activity: |
Charles Brown
|
||||||||||||
| Senior Public Office Holders who were lobbied in this activity: |
Susan Bouma,
Executive Director
Therapeutic Assessment & Access, Health John Capelli, Executive Director Pharmaceutical Policy, Legislation & Engagement Branch, Health Sarah Pugh, Executive Director Health Ian Rongve, ADM Ministry of Health, Health |
||||||||||||
|
|||||||||||||
| Senior officer who filed this Lobbying Activity Report: | Bettina Hamelin | ||||||||||||
| The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not. | |||||||||||||
- Date Modified: